Bristol Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.37M Buy
40,000
+18,000
+82% +$637K 3.18% 8
2018
Q4
$702K Buy
+22,000
New +$857K 0.84% 21
2018
Q3
Sell
-20,000
Closed -$620K 80
2018
Q2
$620K Sell
20,000
-80,000
-80% -$1.87M 1.22% 20
2018
Q1
$1.48M Hold
100,000
4.82% 6
2017
Q4
$1.55M Buy
100,000
+81,000
+426% +$1.2M 0.97% 26
2017
Q3
$237K Sell
19,000
-1,000
-5% -$11.2K 0.24% 60
2017
Q2
$216K Buy
+20,000
New +$196K 0.14% 46
2017
Q1
Sell
-20,000
Closed -$217K 86
2016
Q4
$217K Buy
+20,000
New +$203K 0.22% 57

Other funds holding STAA

Bristol Advisors's STAA Position: Q1 2019 in Review

Bristol Advisors increased its STAAR Surgical (STAA) stake by 82% in Q1 2019, buying an estimated $637K and bringing the position to 40,000 shares worth $1.37M. The position accounts for 3.18% of the portfolio, ranked #8.

Bristol Advisors first reported a position in STAA in Q4 2016 and has held it in 8 quarters since. The position peaked at $1.55M in Q4 2017. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2019.

  • Bristol Advisors held 40,000 shares of STAAR Surgical worth $1.37M as of Q1 2019.
  • Bristol Advisors bought 18,000 STAAR Surgical shares in Q1 2019, an estimated $637K.
  • STAAR Surgical made up 3.18% of Bristol Advisors's portfolio in Q1 2019, its #8 holding.
  • Bristol Advisors first reported a position in STAAR Surgical in Q4 2016 and has held it in 8 quarters since.
  • Bristol Advisors's STAAR Surgical position peaked at $1.55M in Q4 2017.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2019.

Based on Bristol Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.